| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $4.16B | $2.16B | $2.51B |
| YoY Revenue Growth % | +92.4% | -13.7% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$182.1M | $351.0M | $803.3M |
| Operating Margin % | -4.4% | 16.2% | 32.0% |
| Net Income (GAAP) | -$153.2M | $286.4M | $655.9M |
| EBITDA (Normalized) | $45.6M | $493.4M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $305.8M | $476.4M | $857.9M |
| Capital Expenditures (CapEx) | $284.6M | $178.0M | — |
| Free Cash Flow (FCF) | $21.2M | $298.4M | $857.9M |
| FCF Margin % | 0.5% | 13.8% | 34.2% |
| Return on Invested Capital (ROIC %) | -4.0% | 22.4% | — |
| Cash & Short-Term Equivalents | $432.2M | $408.2M | — |
| Total Debt (Short + Long Term) | $317.3M | $79.5M | — |
| Total Stockholders' Equity | $3.68B | $1.57B | — |